Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics
Salvador Fudio, Alvaro Sellers, Laura Pérez Ramos, Beatriz Gil-Alberdi, Ali Zeaiter, Mikel Urroz, Antonio J. Carcas, Rubin Lubomirov
Topics & Concepts
MedicineTolerabilityClinical trialExpeditingDrug developmentDosingPharmacokineticsDrugPharmacologyIntensive care medicinePopulationClinical researchClinical study designOncologyCancerClinical pharmacologyInternal medicineAdverse effectEnvironmental healthSystems engineeringEngineeringCancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchComputational Drug Discovery Methods